Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8957059rdf:typepubmed:Citationlld:pubmed
pubmed-article:8957059lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8957059lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:8957059lifeskim:mentionsumls-concept:C1879526lld:lifeskim
pubmed-article:8957059lifeskim:mentionsumls-concept:C0045811lld:lifeskim
pubmed-article:8957059lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8957059lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:8957059pubmed:issue10lld:pubmed
pubmed-article:8957059pubmed:dateCreated1997-1-7lld:pubmed
pubmed-article:8957059pubmed:abstractText2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces aberrant crypt foci (ACFs) as well as colon cancer in F344 male rats. Conditions allowing rapid development of ACFs over a short period were investigated. F344 male rats were fed 400 ppm of PhIP x HCl in a low-fat diet (LF) for 2 weeks and then given a PhIP-free, high-fat diet containing PRIMEX (HF-PR) or safflower oil, or PhIP-free LF for 4 or 12 weeks. Rats fed HF-PR for 4 weeks gave the highest number of ACFs/rat (3.3) and their size in terms of aberrant crypts/ACF (2.7) was much larger than that obtained with conventional continuous feeding of PhIP for 25 weeks in the CE-2 diet. Therefore, 2 weeks of dietary exposure to 400 ppm of PhIP x HCl, followed by HF-PR for 4 weeks, is a practical and convenient method for obtaining ACFs. This protocol should be useful for studies of the early phase of colon carcinogenesis.lld:pubmed
pubmed-article:8957059pubmed:languageenglld:pubmed
pubmed-article:8957059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957059pubmed:citationSubsetIMlld:pubmed
pubmed-article:8957059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957059pubmed:statusMEDLINElld:pubmed
pubmed-article:8957059pubmed:monthOctlld:pubmed
pubmed-article:8957059pubmed:issn0910-5050lld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:SugimuraTTlld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:WatanabeMMlld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:NagaoMMlld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:OchiaiMMlld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:IshiguroYYlld:pubmed
pubmed-article:8957059pubmed:authorpubmed-author:NakagamaHHlld:pubmed
pubmed-article:8957059pubmed:issnTypePrintlld:pubmed
pubmed-article:8957059pubmed:volume87lld:pubmed
pubmed-article:8957059pubmed:ownerNLMlld:pubmed
pubmed-article:8957059pubmed:authorsCompleteYlld:pubmed
pubmed-article:8957059pubmed:pagination1029-33lld:pubmed
pubmed-article:8957059pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:meshHeadingpubmed-meshheading:8957059-...lld:pubmed
pubmed-article:8957059pubmed:year1996lld:pubmed
pubmed-article:8957059pubmed:articleTitleEfficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.lld:pubmed
pubmed-article:8957059pubmed:affiliationCarcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.lld:pubmed
pubmed-article:8957059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8957059pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8957059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8957059lld:pubmed